Examples of Potential Risks from BBTsSource: Office of Technology Assessment, U.S. Congress, 1995; Chapter 4, page 71 | ||
BBT examples | Potential environmental impacts | Potential human health effects |
Conservation of natural enemies | Probably insignificant | No known risk (no known risk indicates that risks have not been documented. In some cases, the absence of document effects may be due to a lack of monitoring or observation.) |
Classical biological control/ introduction of new natural enemies | Some adverse impacts on nontarget organisms; destabilization of existing control by predators and parasites; habitat destruction; possible evolutionary changes. Many of these risks are shared by other BBTs. | No known risk |
Release of sterile fishes for biological control | Adverse effects on nontarget organisms; potential for hybridization with wild forms; possible development of resistance, self-reproducing strains, or selective mating patterns; potential transmission of parasites | No known risk. |
Augmentative releases of parasites and predators | Some risks similar to those for classical biological control; contamination of field-harvested natural enemies by parasites; depletion of natural enemies in collection sites. | Allergic reactions among workers in insectaries |
Phermones | Potential adverse impacts on aquatic invertebrates and some fish from lepidopteran varieties but warning labels advise against such usage; other types of phermones may have greater potential toxicity to mammals, fish, birds; undocumented possibility for disruption of mating behavior of other insects; slight risk of resistance. | Low oral or inhalation toxicity, possible dermal and eye irritation from lepidopteran-active products; higher toxicity among other phermone groups, but minimal human exposure. |
Bacterial pathogens (microbial pesticides) | Some adverse impacts on nontarget lepidoptera and their avian predators. Short-term declines in certain nontarget insects; resistance documented in field populations of pests treated regularly with Bt. | Minimal risk to general population; some data suggest possible infection of immunocompromised individuals. |
Viral pathogens (microbial pesticides) | Minimal effects on nontarget organisms; possibility of resistance in future as field use expands. | No known risk |
Fungal pathogens (microbial pesticides) | Possible effects on nontarget organisms; early evidence of resistance | Some established human allergens and toxic metabolites |
Protozoan pathogens (microbial pesticides) | Possible effects on nontarget species | No known risk |
Nematodes (microbial pesticides) | Possible effects on nontarget organisms particularly those in the soil. | No known risk |
Release of sterile insects | Some adverse effects on nontarget organisms; possible development of resistance, self-producing strains, or selective mating patterns. | No known risk |
Back to SERAMBO |
Back to Natural Resources |
Back to Human Health |
Questions? Email us! |